Our products are in development, are not for sale, and do not have marketing approval or clearance from regulatory authorities in any jurisdiction.
Testing designed to fit how emergency medicine physicians evaluate hard to diagnose patients
Inflammatix Initiates TriVerity™ for Improved Management of Emergency Department Patients with Suspected Infections (TIMED) Trial
Our products are in development, are not for sale, and do not have marketing approval or clearance from regulatory authorities in any jurisdiction.
Interpreting the immune response, the TriVerity test informs on key clinically actionable questions:
-
Does the patient have a bacterial or viral infection or a noninfectious condition?
-
Is the patient likely to need ICU-level intervention?
The power of the immune response to diagnose acute infections and sepsis
Emergency departments across the US routinely see patients suspected of acute infection and sepsis
In up to half of these patients, physicians struggle to make proper diagnosis and prognosis and would welcome novel tools to assist them.1
IMMUNE RESPONSE
Expertise in interpreting the immune response
Leveraging our expertise in bioinformatics, including machine learning and artificial intelligence, and molecular biology, we are harnessing the ability to interpret the immune response to develop tests aimed to help physicians make confident and timely clinical decisions.
